These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 25158326)

  • 1. [Carcinogenic pathways and natural history of upper tract urothelial carcinomas: state-of-the-art review for the yearly scientific report of the French National Association of Urology].
    Seisen T; Cancel-Tassin G; Colin P; Cussenot O; Rouprêt M
    Prog Urol; 2014 Nov; 24(15):943-53. PubMed ID: 25158326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathologic analysis of upper tract urothelial carcinomas: state of the art review for the yearly scientific report of the French National Association of Urology].
    Varinot J; Colin P; Rouprêt M; Leroy X; Comperat E
    Prog Urol; 2014 Nov; 24(15):954-65. PubMed ID: 25199727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidemiology and risk factors of upper urinary tract tumors: literature review for the yearly scientific report of the French National Association of Urology].
    Ouzzane A; Rouprêt M; Leon P; Yates DR; Colin P
    Prog Urol; 2014 Nov; 24(15):966-76. PubMed ID: 25158329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Imaging of urothelial carcinomas of the upper tract: state of the art review for the yearly scientific report of the National French Association of Urology].
    Puech P; Rouprêt M; Renard-Penna R; Lemaître L; Colin P
    Prog Urol; 2014 Nov; 24(15):987-99. PubMed ID: 25224591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic factors of upper tract urothelial carcinomas and impact on survival: a systematic review for the yearly scientific report of the French National Association of Urology].
    Colin P; Irani J; Drouin SJ; Shariat SF; Rouprêt M
    Prog Urol; 2014 Nov; 24(15):1000-10. PubMed ID: 25199726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Non-surgical treatment modalities available for the treatment of upper tract urothelial carcinomas: state-of-the-art review for the yearly scientific report of the French National Association of Urology].
    Audenet F; Rouprêt M; Houédé N; Colin P
    Prog Urol; 2014 Nov; 24(15):1030-40. PubMed ID: 25208728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical, ureteroscopic and photodynamic diagnosis of urothelial carcinomas of the upper tract: state-of-the art review for the yearly scientific report of the French National Association of Urology].
    Nison L; Bozzini G; Rouprêt M; Traxer O; Colin P
    Prog Urol; 2014 Nov; 24(15):977-86. PubMed ID: 25199724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Conservative management of urothelial carcinomas of the upper tract: systematic review for the yearly scientific report of the French National Association of Urology].
    Pignot G; Colin P; Rouprêt M; Traxer O
    Prog Urol; 2014 Nov; 24(15):1011-20. PubMed ID: 25205341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular changes in development and progression of urothelial carcinoma].
    Hartmann A
    Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant Association of Cyclo-oxygenase 2 Genotypes with Upper Tract Urothelial Cancer.
    Chang WS; Liao CH; Hsu CM; Huang CY; Fang HY; Kao PY; Tsai CW; Wu HC; Hu PS; Wang TC; Syu YR; Shui HA; Bau DT
    Anticancer Res; 2015 May; 35(5):2725-30. PubMed ID: 25964551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgical treatment of upper tract urothelial carcinomas by nephroureterectomy: state of the art review for the yearly scientific report of the French National Association of Urology].
    Neuzillet Y; Colin P; Phé V; Shariat SF; Rouprêt M
    Prog Urol; 2014 Nov; 24(15):1021-9. PubMed ID: 25158323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.
    Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Gontero P; Van Rhijn BWG; Mostafid AH; Palou J; Shariat SF
    Eur Urol; 2018 Jan; 73(1):111-122. PubMed ID: 28867446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review.
    Cutress ML; Stewart GD; Zakikhani P; Phipps S; Thomas BG; Tolley DA
    BJU Int; 2012 Sep; 110(5):614-28. PubMed ID: 22471401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPX2 underexpression indicates poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder.
    Chang IW; Lin VC; Hung CH; Wang HP; Lin YY; Wu WJ; Huang CN; Li CC; Li WM; Wu JY; Li CF
    World J Urol; 2015 Nov; 33(11):1777-89. PubMed ID: 25813210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular aspects of upper tract urothelial carcinoma.
    Patel N; Arya M; Muneer A; Powles T; Sullivan M; Hines J; Kelly J
    Urol Oncol; 2014 Jan; 32(1):28.e11-20. PubMed ID: 23428541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programmed Death-ligand 1 Expression in Upper Tract Urothelial Carcinoma.
    Skala SL; Liu TY; Udager AM; Weizer AZ; Montgomery JS; Palapattu GS; Siddiqui J; Cao X; Fields K; Abugharib AE; Soliman M; Hafez KS; Miller D; Lee CT; Alva A; Chinnaiyan AM; Morgan TM; Spratt DE; Jiang H; Mehra R
    Eur Urol Focus; 2017 Oct; 3(4-5):502-509. PubMed ID: 28753826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma.
    Audenet F; Isharwal S; Cha EK; Donoghue MTA; Drill EN; Ostrovnaya I; Pietzak EJ; Sfakianos JP; Bagrodia A; Murugan P; Dalbagni G; Donahue TF; Rosenberg JE; Bajorin DF; Arcila ME; Hechtman JF; Berger MF; Taylor BS; Al-Ahmadie H; Iyer G; Bochner BH; Coleman JA; Solit DB
    Clin Cancer Res; 2019 Feb; 25(3):967-976. PubMed ID: 30352907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer.
    Skeldon SC; Semotiuk K; Aronson M; Holter S; Gallinger S; Pollett A; Kuk C; van Rhijn B; Bostrom P; Cohen Z; Fleshner NE; Jewett MA; Hanna S; Shariat SF; Van Der Kwast TH; Evans A; Catto J; Bapat B; Zlotta AR
    Eur Urol; 2013 Feb; 63(2):379-85. PubMed ID: 22883484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
    Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Böhle A; Van Rhijn BW; Kaasinen E; Palou J; Shariat SF
    Eur Urol; 2015 Nov; 68(5):868-79. PubMed ID: 26188393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.